109 related articles for article (PubMed ID: 20460531)
1. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
[TBL] [Abstract][Full Text] [Related]
2. In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions.
Delaunay-Lemarie C; Vincourt JB; Marie B; Battaglia-Hsu SF; Etienne S; Sirveaux F; Nguyen Thi PL; Magdalou J; Vignaud JM; Gauchotte G
Virchows Arch; 2015 Sep; 467(3):329-37. PubMed ID: 26100916
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
4. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
8. Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.
Ho L; Stojanovski A; Whetstone H; Wei QX; Mau E; Wunder JS; Alman B
Cancer Cell; 2009 Aug; 16(2):126-36. PubMed ID: 19647223
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
[TBL] [Abstract][Full Text] [Related]
10. Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression.
Oxford JT; Doege KJ; Horton WE; Morris NP
Exp Cell Res; 1994 Jul; 213(1):28-36. PubMed ID: 8020600
[TBL] [Abstract][Full Text] [Related]
11. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
[TBL] [Abstract][Full Text] [Related]
12. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.
Wang XM; Yu DM; McCaughan GW; Gorrell MD
Hepatology; 2005 Oct; 42(4):935-45. PubMed ID: 16175601
[TBL] [Abstract][Full Text] [Related]
14. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
15. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
Amling M; Pösl M; Hentz MW; Priemel M; Delling G
Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.
Lehmann W; Edgar CM; Wang K; Cho TJ; Barnes GL; Kakar S; Graves DT; Rueger JM; Gerstenfeld LC; Einhorn TA
Bone; 2005 Feb; 36(2):300-10. PubMed ID: 15780956
[TBL] [Abstract][Full Text] [Related]
18. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
19. Chondrocyte and chondrosarcoma cell integrins with affinity for collagen type II and their response to mechanical stress.
Holmvall K; Camper L; Johansson S; Kimura JH; Lundgren-Akerlund E
Exp Cell Res; 1995 Dec; 221(2):496-503. PubMed ID: 7493650
[TBL] [Abstract][Full Text] [Related]
20. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
